In patients with cancer, systemic microvascular metastases and bone marrow involvement can cause microangiopathic hemolytic anemia and thrombocytopenia. This occurs most often in patients with known ...

WASHINGTON (Reuters) - Genentech Inc has warned doctors about a type of anemia seen in patients treated with the company's blockbuster cancer drug Avastin in combination with Pfizer Inc's Sutent in a ...

July 14, 2008 — Several studies of bevacizumab (Avastin, Genentech, Inc) plus sunitinib malate (Sutent, Pfizer, Inc) have been halted due to reports of microangiopathic hemolytic anemia (MAHA), the US ...

Genentech has received reports of several cases of microangiopathic hemolytic anemia (MAHA) in patients with solid tumors receiving Avastin (bevacizumab) in combination with Sutent (sunitinib malate, ...

Dr. Florence H. Porterfield (Medicine): A 71-year-old woman was admitted to this hospital because of refractory hemolytic anemia. The patient, who had recurrent breast cancer and diffuse cutaneous ...

Physical/chemical causes. These causes of hemolysis are most often secondary to improper handling of blood products. Reasons include inadvertent heating or freezing with subsequent thawing of the red ...

Are you a member of an institution such as a university or hospital?Learn more about Institutional Access From the Medical Research Council Group for the Study of Hemolytic Mechanisms (address reprint ...

Anemia and hemolytic anemia are both conditions that result in too few red blood cells (RBCs). Their causes are different, but both have similar symptoms and can lead to long-term complications. Share ...

The researchers noted that their paper is the first, to their knowledge, to report on a case of thrombocytopenic purpura (TTP) in a patient with metastatic renal cell carcinoma (RCC). Authors of a new ...

A diagnosis of thrombotic microangiopathy on kidney biopsy in a patient presenting with hypertensive emergency has historically elicited the diagnosis of malignant hypertension-associated thrombotic ...